Glucose Metabolism of Hippocampal Subfields in Medial Temporal Lobe Epilepsy

Tse-Hao Lee,Yen-Cheng Shih,Yi-Jiun Lu,Chien-Chen Chou,Cheng-Chia Lee,Hsiang-Yu Yu,Syu-Jyun Peng
DOI: https://doi.org/10.1097/rlu.0000000000005105
IF: 10.6
2024-03-04
Clinical Nuclear Medicine
Abstract:Hippocampal sclerosis (HS) is the most common form of drug-resistant epilepsy in adults. The pathological characteristics of HS include neuronal loss and chronic fibrillary gliosis centered on the pyramidal cell layer and/or neuronal loss involving the CA1 subfields. These effects are accompanied by granule cell dispersion, mossy fiber sprouting, and interneuronal alterations. 1 The hippocampal formation comprises a number of distinct interacting subregions, which distinct interacting subregions operating together in the form of complex heterogeneous structures referred to as subfields. These subfields present distinct cytoarchitectures, connectivity, and functions, whether in a healthy or diseased state. 2–5 An understanding of the internal network architecture could help to elucidate the mechanisms underlying intractable epilepsy and neurocognitive impairment. Advances in neuroimage segmentation and volumetry have made it possible to visualize the internal structures of the hippocampus in vivo. 6 The study of hippocampal subfields has attracted particular attention in the research of Alzheimer disease (AD). 7 Hippocampal subfield analysis based on PET-MRI has proven far more effective than global hippocampal assessments in detecting pathological changes associated with AD. 8 In cases of medial temporal lobe epilepsy (MTLE), 18 F-FDG PET has been used to observe brain glucose metabolism and lateralize seizure focus in assessing the suitability of patients for epilepsy surgery and predicting surgical outcomes. 9,10 Neuroimaging has seldom been used to observe glucose metabolism in the hippocampal subfields of patients with MTLE.
radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?